Related Experiment Videos

RNA interference targeting Akt promotes apoptosis in hypoxia-exposed human neuroblastoma cells

Xiu-Huai Liu1, Erik Z Yu, Ying-Yue Li

  • 1Department of Pathology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-4799, USA. liuxiuhuai@mail.nih.gov

Brain Research
|January 13, 2006
PubMed

Insights

Targeting Akt with siRNA induces cancer cell death, particularly under anoxia/reoxygenation (A/R). This highlights Akt signaling

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The phosphoinositide 3-kinase (PI3K)/Akt pathway is crucial for tumor development and progression.
  • Akt is frequently hyperactivated in various cancers, including neuroblastoma and glioma.
  • Anoxia/reoxygenation (A/R) can influence malignant tumor growth and progression.

Purpose of the Study:

  • To evaluate the therapeutic potential of small interfering RNA (siRNA) targeting Akt.
  • To investigate Akt siRNA's efficacy in inducing apoptotic cell death in neuroblastoma cells.
  • To assess the impact of A/R conditions on Akt siRNA's therapeutic effect.

Main Methods:

  • Utilized NBFL cells, a human neuroblastoma cell line.
  • Administered siRNA targeting Akt.
  • Exposed cells to normoxic and anoxia/reoxygenation (A/R) conditions.
  • Assessed apoptotic cell death using TUNEL assay and activated caspase-3 immunoreactivity.

Main Results:

  • siRNA targeting Akt effectively induced apoptotic cell death in NBFL cells under normoxic conditions.
  • The apoptotic effect was significantly enhanced when cells were subjected to A/R.
  • Activated caspase-3 and TUNEL assays confirmed apoptosis induction.

Conclusions:

  • Akt signaling is vital for neuroblastoma cell survival.
  • Targeting Akt with siRNA demonstrates therapeutic potential for neuroblastoma treatment.
  • Combining Akt inhibition with A/R conditions may enhance therapeutic efficacy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...